For generations, homeowners have clearly thought of windows when they heard the term glazing. Single, double and in the meantime also three or four times glazed windows - the properties of the glass however have changed dramatically. Noise and temperature insulation are features and also - if desired - opacity just by pressing a button. Now glass is increasingly becoming a facade, as a solar panel, as insulation or as a photovoltaic system. For Architects this development is really fantastic.
Longwood Gardens, one of America’s most beloved gardens in the heart of Pennsylvania’s historic Brandywine Valley, has just unveiled the largest chrysanthemum ever grown in North America—a single plant with 991 blooms measuring more than 11 feet in diameter.
Called the Thousand Bloom, this plant derives its name from the ambitious goal of cultivating a single chrysanthemum plant to produce as many perfectly placed blooms as possible. This ancient technique, known in Japan as Ozukuri, originated more than 200 years ago in Asia and is the most exacting and challenging of all Chrysanthemum training styles.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/longwoodgardens/47011/
Texas Instruments (TI) (NASDAQ: TXN) today introduced the first all-in-one USB Type-C and USB Power Delivery (PD) controller, which integrates a port power switch and port data multiplexer. The TPS65982 USB PD controller is the only integrated circuit (IC) available that provides the full power path, operating as a Single- or Dual-Role Port and enabling a variety of host and device power implementations.
For applications requiring higher data rates, the TPS65982 can be combined with the 5.4-Gbps HD3SS460, the industry’s first USB Type-C cross-point switch. This solution enables USB connectors on either end of the cable to be flipped up or down, delivers power up to 100 W, and supports Alternate Modes to distribute video over DisplayPort from the host to the end device.
To view the multimedia news release visit
http://www.multivu.com/players/English/70647529-texas-instruments-usb-type-c/
For those who enjoy an icy cup of cold brew coffee, the new KitchenAid Cold Brew Coffee Maker is the perfect gift to get them brewing at home. The thoughtful and streamlined design allows for easy home brewing in three simple steps: grind, brew and pour. The model’s no heat brewing method steeps coarsely ground coffee in cold water for 12-24 hours, resulting in a smooth and balanced flavor that can be enjoyed all day. Capable of making up to 28 ounces of concentrate at once (or approximately 14 average single servings), the resulting brew is best enjoyed by combining 2 ounces of coffee concentrate with ice and the option of milk and sweeteners.
Designed with a modern glass brew jar and sleek stainless steel tap, the cold brew coffee maker serves as a stylish addition to any kitchen countertop, while the compact footprint provides an ideal fit for a refrigerator shelf or door for easy dispensing straight from the refrigerator. A reusable stainless steel steeper allows for custom beverage brewing, aided by a fill guideline that takes the guesswork out of the process. The easy to clean glass and stainless components help to preserve taste in combination with a fitted lid that ensures freshness of the coffee concentrate. The KitchenAid® Cold Brew Coffee Maker is available now in stainless steel at a suggested retail price of $129.99.
To view the multimedia release go to:
https://www.multivu.com/players/English/8013854-coffee-tools-from-kitchenaid/
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
